FET Clinical Trials

256 recruitingLast updated: May 13, 2026

There are 256 actively recruiting fet clinical trials across 55 countries. Studies span Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1. Top locations include Madrid, Spain, New York, New York, United States, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


FET Trials at a Glance

256 actively recruiting trials for fet are listed on ClinicalTrialsFinder across 6 cities in 55 countries. The largest study group is Not Applicable with 87 trials, with the heaviest enrollment activity in Madrid, New York, and Barcelona. Lead sponsors running fet studies include Regional Cardiology Center, The Copper Health Centre (MCZ),, Assistance Publique - Hôpitaux de Paris, and Changchun GeneScience Pharmaceutical Co., Ltd..

Treatments under study

About FET Clinical Trials

Looking for clinical trials for FET? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new FET trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about FET clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 256 trials

Recruiting
Not Applicable

Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial

PrematureInfant MalnutritionLight-For-Dates With Signs of Fetal Malnutrition+1 more
University of Alabama at Birmingham152 enrolled1 locationNCT06207071
Recruiting
Phase 3

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC120 enrolled61 locationsNCT05912517
Recruiting

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Hemolytic Disease of the Fetus and Newborn
Janssen Research & Development, LLC175 enrolled12 locationsNCT07194070
Recruiting
Not Applicable

Advanced Wireless Sensors for Neonatal Care in the Delivery Room

Pregnancy RelatedParentsECG Electrode Site Reaction+14 more
Guilherme Sant'Anna, MD600 enrolled5 locationsNCT06693817
Recruiting

Scottish Advanced Fetal Research Study

Life StyleHumanFetal Development+1 more
University of Aberdeen1,200 enrolled1 locationNCT04613583
Recruiting

Electrophysiology of Fetal Arrhythmia

Fetal Arrhythmia
University of Wisconsin, Madison450 enrolled1 locationNCT03047161
Recruiting
Phase 1

A First in Human Study of the Safety, Tolerability, and the Physiologically Based Pharmacokinetics of XFB19 in Healthy Adult Volunteers.

Focus of the Study: Safety of XFB19
Xfibra, Inc.40 enrolled1 locationNCT05361733
Recruiting
Not Applicable

Digital Microlearning and Patient Safety in Nursing Students

Patient SafetyMedical Education
Agri Ibrahim Cecen University100 enrolled1 locationNCT07367906
Recruiting
Not Applicable

Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders

Fetal Alcohol Spectrum Disorders
University of Rochester60 enrolled1 locationNCT07016009
Recruiting

Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism

Efficacy and SafetyHyperthyroidism/ThyrotoxicosisComplication Rate+1 more
Chinese PLA General Hospital454 enrolled1 locationNCT07557810
Recruiting
Not Applicable

The Effectiveness of Gamified Metaverse-Based Training on Patient Safety for Nursing Students

Patient SafetyNursing EducationGamification+1 more
Baskent University60 enrolled1 locationNCT07394907
Recruiting
Phase 3

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group

Long Term Efficacy and Safety
Hansa Biopharma AB150 enrolled14 locationsNCT05937750
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting
Phase 1

A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors

Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines140 enrolled20 locationsNCT06427941
Recruiting

The Combined First Trimester Screening

Fetal Growth RestrictionPreterm LaborPreeclampsia (PE)+4 more
Institute of Health Information and Statistics of the Czech Republic2,000 enrolled3 locationsNCT07015203
Recruiting
Not Applicable

Operating Room Black Box Supported Debriefings and Their Effect on Healthcare Professionals Effectiveness and Psychological Safety.

StressResiliencePsychological Safety+2 more
ORNND - Operating Room Nurse Network Denmark135 enrolled3 locationsNCT07396675
Recruiting
Phase 1

A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)

SafetyTolerabilityAdult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd.64 enrolled1 locationNCT07016802
Recruiting

Mediterranean Diet on Pregnancy and Foetus Development

Pregnancy OutcomesInfant DevelopmentFetal Development
Neuromed IRCCS2,000 enrolled1 locationNCT05403632
Recruiting
Not Applicable

Castor Oil Ingestion and Balloon Catheter for Labor Induction in Nulliparous

Induction of Labor Affected Fetus / Newborn
Holy Family Hospital, Nazareth, Israel142 enrolled2 locationsNCT06325007
Recruiting
Phase 3

Study of Placental Vascularization Using Contrast Ultrasound

Fetal Growth Restriction
Central Hospital, Nancy, France30 enrolled1 locationNCT06497959